Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

RPTX Repare Therapeutics Inc

3,51

-0,02 (-0,57%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Repare Therapeutics Charts.

News Repare Therapeutics Inc

Small Cap Massively Bid Following Key Q1 Earnings Beat
Mittwoch 8 Mai 2024 (1 Woche vor) • AllPennyStocks.com

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
Dienstag 7 Mai 2024 (2 Wochen vor) • Business Wire

DEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT D’UN PREMIER PATIENT DANS LE CADRE DE L’ÉTUDE DE PHASE 1/1B MYTHIC ÉVALUANT LA COMBINATION D’INHIBITEURS WEE1 ET PKMYT1 GÉNÉRANT UNE LÉTHALITÉ SYNTHÉTIQUE
Dienstag 30 April 2024 (3 Wochen vor) • Business Wire

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
Freitag 26 April 2024 (3 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Donnerstag 29 Februar 2024 (3 Monate vor) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 28 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mittwoch 28 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 28 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Repare Therapeutics Inc News-Artikel

Merchants and Marine Ban... (QX)

Smart Trust California M...

Highland Gold Mining Ld

Richard Bernstein Adviso...

Leverage Shares 3x Short...

China Infrastructure Con... (PK)

Highstreet token

Teleperformance SE 1.5% ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen